NSE · EPIGRAL · Chemicals
Epigral Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹705 Cr with net profit ₹99 Cr — a 14.06% net margin, versus 13.06% the period before.
Shareholding
As of 2026-06-30
- Promoter68.83%
- Public24.58%
- FII1.03%
- DII5.56%
76,305 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.62× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #33 of 159 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Pidilite Industries Ltd. | ₹1,65,890 Cr | 67.35 | 15.31 | 22.61% | 16.77% |
| Solar Industries India Ltd. | ₹1,63,362 Cr | 93.51 | 26.02 | 26.72% | 17.05% |
| SRF Ltd. | ₹77,213 Cr | 34.46 | 5.5 | 13.07% | 13.01% |
| Linde India Limited | ₹56,603 Cr | 103.24 | 13.27 | 12.87% | 21.69% |
| Gujarat Fluorochemicals Ltd. | ₹48,279 Cr | 443.04 | 6.19 | 7.3% | 11.49% |
| Godrej Industries Ltd. | ₹44,101 Cr | 99.27 | 3.95 | 11.1% | 5.58% |
| Himadri Speciality Chem Limited | ₹38,370 Cr | 191.08 | 8.15 | 15.96% | 16.12% |
| Navin Fluorine International Ltd. | ₹37,898 Cr | 58.47 | 9.53 | 16.69% | 20.02% |
| Deepak Nitrite Ltd. | ₹22,422 Cr | 102.04 | 3.84 | 9.43% | 6.98% |
| Atul Ltd. | ₹20,029 Cr | 95.31 | 3.22 | 9.31% | 8.93% |
| Epigral Limited(this company) | ₹4,768 Cr | 58.92 | 2.15 | 14.94% | 13.14% |
AI analysis
AI-generated · google/gemini-2.5-flashEpigral Limited, trading as EPIGRAL, has a market capitalization of Rs 4673 Cr. The company reported revenue of Rs 2542.16 Cr and a profit margin of 13.14%. Its earnings per share (EPS) stood at Rs 76.38, with a return on equity (ROE) of 14.94% and return on capital employed (ROCE) of 14.69%. The debt-to-equity ratio was 0.28.
Positives
- +The debt-to-equity ratio is low at 0.28.
- +The promoter holding is substantial at 68.8285%.
- +There are no promoter shares pledged (0%).
- +The company is not under surveillance.
Negatives
- −Revenue growth for the annual period ending March 2026 was negative at -0.9%.
- −Promoter holding has decreased from 71.1805% in March 2022 to 68.8285% in June 2026.
- −FII holdings have decreased from 1.1457% in December 2022 to 1.0341% in June 2026.
- −The dividend yield is unspecified at 46%, making assessment difficult.
Financial Performance
Epigral Limited reported annual revenue of Rs 2542.16 Cr as of March 2026. The revenue growth stood at -0.9%. The net profit for the same period was Rs 331.97 Cr. The company's EPS was Rs 76.38 for the period ending March 2026.
Profitability & Returns
The company recorded a profit margin of 13.14%. Return on equity (ROE) for Epigral Limited was 14.94%, and return on capital employed (ROCE) was 14.69%. The earnings per share (EPS) were Rs 76.38.
Balance Sheet
Epigral Limited maintained a debt-to-equity ratio of 0.28, indicating a low level of debt relative to equity. The book value per share was Rs 514.92.
Ownership & Pledges
As of June 30, 2026, promoter holding in Epigral Limited was 68.8285%. Domestic Institutional Investors (DII) held 5.5596%, while Foreign Institutional Investors (FII) held 1.0341%. Public shareholding was 24.5778%. There were no promoter pledges reported (0%).
Regulatory & Surveillance
The company is not currently under any surveillance measure.
Data as of — price: 2026-07-30 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.